1999
|
||
|---|---|---|
|
January
January; 43 (1): 1 - 165 |
February
February; 43 (2): 171 - 316 |
March
March; 43 (3): 317 - 439 Supplement: Ten years of ciprofloxacin: the past, present and future |
|
April
April; 43 (4): 441 - 613 |
May
May; 43 (5): 615 - 746 Supplement: Moxifloxacin: a new respiratory quinolone |
June
June; 43 (6): 747 - 852 Supplement: Levofloxacin: an extended spectrum 4-quinolone agent |
|
July
July; 44 (1): 19 - 140 |
August
August; 44 (2): 307 - 305 |
September
September; 44 (3): 309 - 423 Supplement: Quinupristin/dalfopristin - a novel approach for the treatment of serious Gram-positive infections |
|
October
October; 44 (4): 425 - 585 |
November
November; 44 (5): 587 - 724 Supplement: Zanamivir - a breakthrough in influenza |
December
December; 44 (6): 725 - 857 |